Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people in the UK currently suffer with Lyme disease.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
In England, Wales, and Northern Ireland there are approximately 1,000 to 1,500 laboratory confirmed cases every year, and in Scotland there are approximately 500 laboratory diagnosed cases.
Previous studies have shown that there are approximately 2,000 additional cases of Lyme disease per year that are not laboratory confirmed in England and Wales. Lyme disease is more common in Scotland, and Southeast and Southwest England, compared to other parts of the United Kingdom such as Northern Ireland, and cases peak in the spring and summer months.
Lyme disease is not a notifiable disease in the UK so the exact number in the community is unclear, as many patients are diagnosed with Lyme disease clinically, without sending samples for testing. Further details on Lyme disease are available at the following link:
https://www.gov.uk/government/collections/lyme-disease-guidance-data-and-analysis
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve glaucoma care through the forthcoming NHS 10-Year Plan.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The 10-Year Health Plan will deliver the three big shifts our National Health Service needs to be fit for the future, from hospital to community, from analogue to digital, and from sickness to prevention. All of these are relevant to preventing and managing conditions such as glaucoma in all parts of the country.
More tests and scans delivered in the community and better joint working between services, will support the management of conditions including glaucoma, closer to home.
The plan will draw directly from the extensive engagement we have undertaken with the public, patients, and staff, including in the eye care sector. We are in the final stages of working on the plan and will publish it shortly.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of reading on the mental health of young people.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
No such assessment has been made. We know that according to research reading helps to reduce stress levels and could be beneficial to mental health and well-being.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential link between oral health and diabetes.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Government recognises that patients with type 1 or type 2 diabetes are at greater risk of developing severe gum disease.
Patients with diabetes need to access effective dental care and local pathways should be developed to support this. Integrated care boards (ICBs) are responsible for assessing the needs of their population and for ensuring that the relevant dental services are available. The NHS England commissioning standard on dental care for people with diabetes provides guidance to ICBs on how to ensure these patients can access the care they need. Further information is available at the following link:
https://www.england.nhs.uk/long-read/commissioning-standard-dental-care-for-people-with-diabetes/
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase awareness of the (a) symptoms and (b) treatment of prostate cancer among men.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England run Help Us Help You campaigns to increase knowledge of cancer symptoms and address the barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. The campaigns focus on a range of symptoms, as well as encouraging body awareness to help people spot symptoms across a wide range of cancers at an earlier point.
The Department continues to advise patients in England to follow National Health Service guidance on the signs and symptoms of several types of cancer, including prostate cancer. This advice is available publicly on the NHS.UK website, at the following link:
https://www.nhs.uk/conditions/prostate-cancer/
Improving access to treatment and care are key priorities for the Government for all cancer types, including prostate cancer. To achieve this, the NHS in England has delivered an extra 40,000 operations, scans, and appointments each week, to ensure early diagnosis and faster treatment. Additionally, the Government will spend £70 million on new radiotherapy machines in England, to ensure the most advanced treatment is available to patients who need it.
The NHS England Cancer Programme also commissions clinical cancer audits, which provide timely evidence for cancer service providers of where patterns of care in England may vary, thereby increasing the consistency of access to treatments, and helping to stimulate improvements in cancer treatment and outcomes for patients, including those with prostate cancer.
To increase awareness of treatment options, the Department is committed to ensuring that all cancer patients in England are offered a Holistic Needs Assessment and Personalised Care and Support Planning, ensuring care is focused on what matters most to each person. This is being delivered in line with the NHS Comprehensive Model for Personalised Care, empowering people to manage their care and the impact of their cancer, and maximise the potential of digital and community-based support.
The National Cancer Plan for England, planned for publication later this year, will include further details on how the NHS will improve outcomes for cancer patients, as well as improving access to treatment and care.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the number of drugs-related deaths; and what discussions he has had with his counterparts in (a) Northern Ireland, (b) Wales and (c) Scotland on this issue.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to ensuring that anyone with a drug or alcohol problem can access the help and support they need, and we recognise the need for evidenced-based, high-quality treatment, to reduce the number of drug related deaths.
Local authorities are responsible for assessing the local need for drug and alcohol prevention and treatment in their area, and for commissioning services to meet those needs. In addition to the Public Health Grant, in 2025/26, the Department is providing a total of £310 million in additional targeted grants to improve drug and alcohol services and recovery support, which includes housing and employment.
The Department has an action plan in place to reduce drug and alcohol-related deaths, which is currently being reviewed to ensure that it is grounded in the latest understanding of the drivers of drug and alcohol related deaths, and is responding to these. In 2024, the Department published guidance for local authorities and their partnerships on how to review adult drug and alcohol-related deaths and near-fatal overdoses, to prevent future deaths.
Alongside the funding allocations, the Department has a range of existing and forthcoming best practice resources and guidance that supports those working in the sector to tailor drug and alcohol treatment services to meet local needs, to improve treatment outcomes. The commissioning quality standard provides guidance to local authorities on how to ensure they have a shared understanding of local need, including the experiences of diverse populations. The commissioning quality standard is available at the following link:
https://www.gov.uk/government/publications/commissioning-quality-standard-alcohol-and-drug-services
The Department continues to work with all local areas to address unmet needs and drug and alcohol misuse deaths, and to drive improvements in the continuity of care. This includes the Unmet Need Toolkit, which can be used by local areas to assess local need and plan to meet it.
As health is a devolved matter, each administration of the United Kingdom takes its own decisions on the provision of treatment and other action to address drug related deaths. Nonetheless, it is important that the four nations work together and share learning to tackle the health harms that drugs pose. This includes through our UK wide legislation to expand access to take home naloxone that has been developed in close partnership with devolved administrations. We will continue to work closely with colleagues in the devolved administrations, to share learning and align our approaches where appropriate.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many men have been diagnosed with testicular cancer in the last 12 months.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Disease Registration Service in NHS England, as the national cancer registry, collects and analyses diagnosis and treatment data on cancer patients in England. Using the Rapid Cancer Registration Data set, there were 1,929 diagnoses of testicular cancer, code ICD10 C62*, between March 2024 and February 2025, the latest available data. Further information on the Rapid Cancer Registration Data set is available at the following link:
https://digital.nhs.uk/ndrs/data/data-sets/rcrd
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure equal access to healthcare treatments in each English region.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department sets national priorities for the National Health Service in England through the 2025 mandate to NHS England, reflecting patients’ priorities to be met across all 42 integrated care boards (ICBs).
ICBs are responsible for commissioning most health and care services in England and the National Health Service Act 2006, as amended by the Health Care Act 2022, places duties on ICBs to arrange healthcare services to meet the needs of their local population within available resources and reduce inequalities in access to, and outcomes from, healthcare services.
ICBs and NHS providers are accountable to NHS England on the delivery of the mandate and provision healthcare treatments across their populations, with the Department holding NHS England to account on this.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to increase funding for the research and development of diagnostic (a) tests and (b) tools to help support GPs to (i) diagnose and (ii) detect less survivable cancers (A) earlier and (B) faster.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Research is crucial in tackling cancer, which is why the Department invests over £1.6 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority.
The level of funding for research and development generally depends on funding applications received. The NIHR continues to welcome high quality, high impact funding applications for research into any aspect of human health and care, including less survivable cancers.
In September 2024, the NIHR awarded £2.4 million to develop an artificial intelligence tool to support general practitioners (GPs) to identify suspected cancer faster and more effectively. It will use lung and pancreatic cancers as the first test cases. The NIHR also funded recently completed, January 2025, research into understanding how GPs use existing national guidance for urgent suspected cancer referral in primary care, with the findings expected to be published later this year.
It is a priority for the Government to support the National Health Service to diagnose cancer earlier and to treat it faster, to improve outcomes for all patients across England. We are improving public awareness of cancer signs and symptoms, streamlining referral routes, and increasing the availability of diagnostic capacity through the roll-out of more community diagnostic centres.
We are also investing an additional £889 million in GPs to reinforce the front door of the NHS, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This is the biggest increase in over a decade. We are committed to ensuring that GPs have the right training and systems to identify cancer. The National Cancer Plan will include further details on how we will improve outcomes for cancer patients. It will aim to speed up diagnosis and treatment and ensure all patients have access to the latest treatments and technology.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply for blood donation.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Blood and Transplant (NHSBT) is responsible for blood services in England. Blood donation in the devolved nations is run by the Scottish National Blood Transfusion Service, the Northern Ireland Blood Transfusion Service, and the Welsh Blood Service
The National Blood Transfusion Committee's shortage plans for red cells and platelets outlines four phases for the supply of blood to hospitals, supported by a framework of actions for NHSBT and hospitals at each phase. Further information on the shortage plans for red cells and platelets is available at the following link:
https://nationalbloodtransfusion.co.uk/recommendations
There has been an Amber Alert, when there is reduced availability of blood for a short or a prolonged period which impacts on clinical activity, in place in England for O group blood since July 2024, due to high hospital demand following a cyber-attack on pathology services in South-East London.
NHSBT has been using a number of initiatives to increase blood donations and in turn improve blood stocks, particularly to increase the diversity of the donor base to meet demand for Ro blood needed by sickle cell patients. The opening and reopening of the Brixton and Southampton donor centres respectively have increased NHSBT’s capacity to collect blood, and communications during National Blood Week have pushed for a million people to become regular donors via local, national, and online channels. The Department continues to work closely with NHSBT to ensure there is the right mix of donors across blood groups to meet hospital demand.